Overall, while the limitations associated with the isolation and subsequent expansion of a CD44+/integrin α2β1hi/CD133+ population would appear to preclude its successful application to the large-scale analysis of prostate CSCs in vitro, it does provide an insight into the proportion of cells within established cell lines, which potentially retain stem characteristics despite long-term culture. The gene discussed is PROM1; the disease is male reproductive organ cancer.